DK20489D0 - 1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser - Google Patents

1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser

Info

Publication number
DK20489D0
DK20489D0 DK020489A DK20489A DK20489D0 DK 20489 D0 DK20489 D0 DK 20489D0 DK 020489 A DK020489 A DK 020489A DK 20489 A DK20489 A DK 20489A DK 20489 D0 DK20489 D0 DK 20489D0
Authority
DK
Denmark
Prior art keywords
compounds
acetic acid
indazol
heterocyclyl
similar
Prior art date
Application number
DK020489A
Other languages
English (en)
Other versions
DK20489A (da
Inventor
Banavara Lakshman Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK20489D0 publication Critical patent/DK20489D0/da
Publication of DK20489A publication Critical patent/DK20489A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK020489A 1988-01-19 1989-01-18 1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser DK20489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/000110 WO1989006651A1 (en) 1988-01-19 1988-01-19 1h-indazole-3-acetic acids as aldose reductase inhibitors

Publications (2)

Publication Number Publication Date
DK20489D0 true DK20489D0 (da) 1989-01-18
DK20489A DK20489A (da) 1989-07-20

Family

ID=22208496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK020489A DK20489A (da) 1988-01-19 1989-01-18 1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser

Country Status (11)

Country Link
EP (1) EP0325375B1 (da)
JP (1) JPH0625136B2 (da)
AT (1) ATE79378T1 (da)
CA (1) CA1335733C (da)
DE (1) DE68902396T2 (da)
DK (1) DK20489A (da)
ES (1) ES2042988T3 (da)
FI (1) FI93834C (da)
IE (1) IE61943B1 (da)
PT (1) PT89469B (da)
WO (1) WO1989006651A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
CN105732640B (zh) * 2010-07-16 2019-01-08 纽约市哥伦比亚大学理事会 醛糖还原酶抑制剂及其用途
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
MX2018016122A (es) * 2016-06-21 2019-08-01 Univ Columbia Inhibidores de aldosa reductasa y metodos de uso.
CN111065392A (zh) 2017-07-28 2020-04-24 应用治疗公司 用于治疗半乳糖血症的组合物和方法
CA3132136A1 (en) * 2019-04-01 2020-10-08 Andrew Wasmuth Inhibitors of aldose reductase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4935269A (da) * 1972-08-05 1974-04-01
JPS5135269A (da) * 1974-09-20 1976-03-25 Hitachi Ltd
JPS58144374A (ja) * 1982-02-23 1983-08-27 Fujisawa Pharmaceut Co Ltd インダゾ−ル酢酸誘導体およびその製造法
JPS5998060A (ja) * 1982-11-27 1984-06-06 Fujisawa Pharmaceut Co Ltd インダゾ−ル誘導体、その製造法および農薬
DE3684410D1 (de) * 1985-11-07 1992-04-23 Pfizer Heterocyclische oxophthalazinylessigsaeure.
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法

Also Published As

Publication number Publication date
DK20489A (da) 1989-07-20
ATE79378T1 (de) 1992-08-15
IE61943B1 (en) 1994-11-30
IE890143L (en) 1989-07-19
EP0325375B1 (en) 1992-08-12
FI903626A0 (fi) 1990-07-18
JPH0625136B2 (ja) 1994-04-06
DE68902396D1 (de) 1992-09-17
EP0325375A1 (en) 1989-07-26
FI93834B (fi) 1995-02-28
PT89469B (pt) 1993-12-31
DE68902396T2 (de) 1992-12-10
FI93834C (fi) 1995-06-12
PT89469A (pt) 1990-02-08
ES2042988T3 (es) 1993-12-16
JPH01216975A (ja) 1989-08-30
WO1989006651A1 (en) 1989-07-27
CA1335733C (en) 1995-05-30

Similar Documents

Publication Publication Date Title
NO894367L (no) System og fremgangsmaate for kvantitativ bestemmelse av konsentrasjonene av flere gasser i boreslam.
DK0624596T3 (da) Tetrazolderivater af galdesyrer, fremgangsmåde tilderes fremstilling og anvendelse af disse forbindelser som lægemidler
DK421187D0 (da) Laegemiddel indeholdende dipyridamol eller mopidamol og o-acetylsalicylsyre eller fysiologisk acceptable salte deraf
DK166789A (da) Substituerede flavonoidforbindelser samt laegemidler indeholdende disse
ES2054919T3 (es) Acidos y esteres 4-(quinolin-2-il-metoxi)fenilaceticos alfa-substituidos en caso dado.
NO883073L (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate for fremstilling av dem, farmasoeytiske preparater paa basis av disse forbindelsene, deres anvendelse saavel som mellomprodukter.
NO933647L (no) Karboksylsyrederivater, legemidler inneholdende disse og fremgangsmåte for deres fremstilling
NO941937D0 (no) Sakarinderivater som inhiberer proteolytiske enzymer
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
DE3785684T2 (de) Pyrrolidinamid-Derivate von Acylaminosäure, pharmazeutische Zusammensetzung und Verwendung.
NO891940D0 (no) Fremgangsmaate for selektivt aa redusere permeabiliteten avoljefrie soner i underjordiske formasjoner.
MY131595A (en) Heterocyclically substituted phenyl-cyclohexane- carboxylic acid derivatives
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
DK0603649T3 (da) Substituerede 4-phenyl-pyridoner og 4-phenyl-2-alkoxypyridiner som HMG-CoA-reduktase-inhibitorer
DK553988D0 (da) 4-aminopyridin-derivater og farmaceutiske praeparater indeholdende disse
DK27389A (da) Acetylerede sukkerethere som blegeaktivatorer og renseevneforstaerkere
DK20489A (da) 1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser
DK433787A (da) 1-phenylquinazolin-1h,3h-2,4-dioner og 1-phenylpyrido oe2,3-daapyrimidin-1h,3h-dioner, estere og syreadditionssalte deraf samt farmaceutiske midler indeholdende saadanne forbindelser
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
DK4487D0 (da) Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
ATE122886T1 (de) Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht.
NO842218L (no) Peptidderivater og anvendelse derav som substrater for kvantitativ bestemmelse av enzymer
NO903967L (no) Dihydrocaffeinsyrederivater og farmasoeytiske preparater som inneholder disse.
DK362288A (da) Homocyclostatin- og cyclostatinholdige peptider og farmaceutiske praeparater indeholdende disse
DK222886D0 (da) Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment